An observational study in Severe Sepsis, sponsored by Klinikum St. Georg gGmbH. Terminated at 1 site in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-02-09.
Sponsored by Klinikum St. Georg gGmbH · Observational
Severe sepsis induces significant changes in expression of insulin- and toll-like receptors, cytokines, markers of apoptosis, and activation of t- and b-lymphocytes.
In patients at early stage of severe sepsis, we investigate the expression of pro- and anti-inflammatory cytokines, chemokines, adhesion-molecules, toll-like receptors, insulin-receptors, markers of apoptosis und of t- and b-cell-activation on a mRNA level.
1,899 studies on the registry are indexed under Sepsis; 462 are open to participants now.
This study's enrollment of 20 is below the median of 160 across 931 observational studies indexed under Sepsis.
Browse Sepsis studies →Klinikum St. Georg gGmbH is the lead sponsor of 9 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients with early stage of severe sepsis and septic shock
Exclusion Criteria:
severity of sepsis
SOFA-Score
Time frame: 96 hours after diagnosis of sepsis
This study is terminated, as verified in Feb 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Klinikum St. Georg gGmbH